https://orcid.org/0000-0001-6533-4325
References
- Zhao SC, Xia M, Tang JC. Associations between metabolik syndrome and clinical benign prostatic hyperplasia in a northern urban Han Chinese population: a prospective cohort study. Sci Rep. 2016;6:1–12. doi:10.1038/s41598-016-0001-8
- Bin LK. Epidemiology of clinical benign prostatic hyperplasi. Asian J Urol. 2017;4(3):148–151. doi:10.1016/j.ajur.2017.06.004
- Chaidir M, Rainy U. Pembesaran prostat jinak (Benign Prostatic Hyperplasia/BPE). 2015;8–33.
- Aslan A, Çırakoğlu A, Kaşko Y. The relationship between body mass index and lower urinary tract symptoms in men. Middle Black Sea J Health Sci. 2019;5(August):138–144.
- Shuster A, Patlas M, Pinthus JH, Mourtzakis M. The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol. 2012;85(1009):1–10. doi:10.1259/bjr/38447238
- Gotera W, Mahadita W, Bakta IM, et al. Waist circumference increased risk of benign prostatic hyperplasia through an increase in the level of interleukin-6 and insulin resistance in abdominal obesity patients. Bali Med J. 2017;6(1):204–210. doi:10.15562/bmj.v6i1.464
- Dahle SE, Chokkalingam AP, Gao Y-T, et al. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol. 2002;168(2):599–604. doi:10.1016/S0022-5347(05)64687-3
- Penson DF, Munro HM, Signorello LB, et al. Urologic diseases in America Project. Obesity, physical activity and lower urinary tract symptoms: results from the Southern Community Cohort Study. J Urol. 2011;186(6):2316–2322. doi:10.1016/j.juro.2011.07.067
- Joseph MA, Harlow SD, Wei JT, et al. Risk factors for lower urinary tract symptoms in a population-based sample of African-American men. Am J Epidemiol. 2003;157:906. doi:10.1093/aje/kwg051
- Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in America project: benign prostatic hyperplasia. J Urol. 2005;173:1256–1261. doi:10.1097/01.ju.0000155709.37840.fe
- Monoarfa RA, Mochtar CA. Validation of Indonesian Version of IPSS. Indonesian J Urol. 2014;21(1):15–19.
- Rohrmann S, Smit E, Giovannucci E, Platz EA. Associations of obesity with lower urinary tract symptoms and noncancer prostate surgery in the third national health and nutrition examination survey. Am J Epidemiol. 2004;159:390. doi:10.1093/aje/kwh060
- Giovannucci E, Rimm EB, Chute CG, et al. Obesity and benign prostatic hyperplasia. Am J Epidemiol. 1994;140:989. doi:10.1093/oxfordjournals.aje.a117206
- Haidinger G, Temml C, Schatzl G, et al. Risk factorsfor lower urinary tract symptoms in elderly men. For the Prostate Study Group of the Austrian Society of Urology. Eur Urol. 2000;37:413. doi:10.1159/000020162
- Wong SY, Woo J, Hong A, et al. Risk factors for lower urinary tract symptoms in southern Chinese men. Urology. 2006;68:1009. doi:10.1016/j.urology.2006.05.039
- Williams G. Aromatase up-regulation, insulin and raised intracellular oestrogens in men, induce adiposity, metabolic syndrome and prostate disease, via aberrant ER-alpha and GPER signalling. Mol Cell Endocrinol. 2012;351:269–278. doi:10.1016/j.mce.2011.12.017
- Parikesit D, Mochtar CA, Umbas R, et al. The impact of obesity towards prostate diseases. Prostate Int. 2016;4(1):1–6. doi:10.1016/j.prnil.2015.08.001
- Penna G, Fibbi B, Amuchastegui S, et al. Human benign prostatic hyperplasia stromal cells as inducers and targets of chronic immuno-mediated inflammation. J Immunol. 2009;182:4056–4064. doi:10.4049/jimmunol.0801875
- Samarinas M, Gravas S. The relationship between inflammation and LUTS/BPH. In: Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia. Academic Press; 2018:31–50.